logo

For the Inventor, By the Inventor

Philadelphia, PA, United States of America

Youhai H Chen

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: University of Pennsylvania, Shenzhen Institutes of Advanced Technology. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youhai H Chen. Retrieved from https://idiyas.com/inventor/youhai-h-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Broomall, PA (US) (2001)
  • Newtown Square, PA (US) (2013)
  • Philadelphia, PA (US) (2018)

Company Filing History:

goldMedal3 out of 2,663 
 
University of Pennsylvania
 patents
silverMedal1 out of 73 
 
Shenzhen Institutes of Advanced Technology
 patents
where one patent can have more than one assignee

Years Active: 2001-2018

Loading Chart...
3 patents (USPTO):Explore Patents
1. 10081810 - C-Rel-specific siRNA and its use for preventing and treating autoimmune psoriasis (2018-09-25),
2. 8609730 - Rel inhibitors and methods of use thereof (2013-12-17),
3. 6211160 - Method for tolerizing a mammalian patient to administration of gene therapy virus vectors (2001-04-03),

Title: Youhai H Chen: Innovator in Autoimmune Research

Introduction

Youhai H Chen is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of autoimmune research, particularly in the development of innovative therapeutic approaches.

Latest Patents

Youhai H Chen holds 3 patents, with his latest inventions focusing on c-Rel-specific small interfering RNA (siRNA) and its applications in preventing and treating autoimmune psoriasis. The first patent details a c-Rel-specific siRNA designed to inhibit c-Rel biosynthesis, thereby preventing and treating autoimmune psoriasis by targeting inflammatory factors associated with the IL-23/IL-17A inflammatory axis. The second patent introduces REL inhibitors that disrupt the DNA binding capacity of REL proteins, offering methods for treating diseases that respond positively to these inhibitors.

Career Highlights

Throughout his career, Youhai H Chen has worked with esteemed institutions such as the University of Pennsylvania and Shenzhen Institutes of Advanced Technology. His research has significantly advanced the understanding of autoimmune conditions and potential treatments.

Collaborations

Youhai H Chen has collaborated with notable colleagues, including James M Wilson and Qingguo Ruan, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Youhai H Chen's work exemplifies the impact of innovative research in the treatment of autoimmune diseases. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…